REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells

By                

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1460-1468

Spandidos Publications

Access to resources Recommend Favorite

Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines

By                

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 13-25

Spandidos Publications

Access to resources Recommend Favorite

Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study

By            

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 299-305

Spandidos Publications

Access to resources Recommend Favorite

Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients

By Park So-Yeon   Hong Yun-Chul   Kim Jin-Hee   Kwak Seung-Min   Cho Jae-Hwa   Lee Hong-Lyeol   Ryu Jeong-Seon  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 489-498

Humana Press, Inc

Access to resources Recommend Favorite

ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer

By                        

Experimental and Therapeutic Medicine, Vol. 2, Iss. 5, 2011-01 ,pp. : 811-815

Spandidos Publications

Access to resources Recommend Favorite